These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1108311)

  • 1. Modification of the rat alloimmune response by enhancing antibodies and the role of blocking factors in the survival of renal grafts.
    Strom TB; Carpenter CB; Garovoy MR; Abbas AK; Corson JM; Bear RA; Soulillou JP
    Transplantation; 1975 Nov; 20(5):368-80. PubMed ID: 1108311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and humoral immunity after allogeneic renal transplantation in the rat. V. Appearance of anti-idiotypic antibody and its relationship to cellular immunity after treatment with donor spleen cells and alloantibody.
    Stuart FP; Scollard DM; McKearn TJ; Fitch FW
    Transplantation; 1976 Nov; 22(5):455-66. PubMed ID: 11579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antibody in rat renal allograft rejection. I. Absence of antibody to erythrocyte-associated antigens is associated with enhanced renal allograft survival.
    Majoor GD; van de Gaar MJ; Vlek LF; van Breda Vriesman PJ
    Transplantation; 1981 May; 31(5):369-75. PubMed ID: 7015624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.
    Majoor GD; Van Breda Vriesman PJ
    Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
    Wasfie T; Reed E; Suciu-Foca N; Hardy MA
    Surgery; 1990 Aug; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
    Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
    Wasowska B; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alloantibody response and active enhancement of some rat renal allografts.
    Desi SB; Ruszkiewicz M
    Transplantation; 1977 Mar; 23(3):230-8. PubMed ID: 324043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of serum-blocking factors by inhibition of allorosette formation in rats with long-surviving renal allografts following short-term postoperative ALS treatment.
    Lie TS; Kanda M; Kim WI; Oehr P; Holst A; Choi SK; Biersack HJ
    Transplantation; 1977 Jan; 23(1):1-6. PubMed ID: 13523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of T cells to accelerated rejection and acceptance of renal allografts in sensitized rat recipients.
    Heidecke CD; Zantl N; Maier S; Sewczik T; Westerholt S; Jakobs F; Westerholt A; Hancock WW; Kupiec-Weglinski JW
    Transplantation; 1998 Nov; 66(10):1354-61. PubMed ID: 9846522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses.
    Downey WE; Baldwin WM; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):160-6. PubMed ID: 2301006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of rejection of organ allografts by alloantibody.
    Morris PJ
    Immunol Rev; 1980; 49():93-125. PubMed ID: 6445324
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged survival of renal allografts in outbred rabbits treated with donor specific F(ab')2 alloantibody.
    Sutherland DE; Howard RJ; Dombrovskis S; Najarian JS
    Ann Surg; 1974 Dec; 180(6):857-63. PubMed ID: 4611361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and humoral immunity after allogeneic transplantation in the rat. 3. The effect of passive antibody on cellular and humoral immunity after allogeneic renal transplantation.
    Biesecker JL; Fitch FW; Rowley DA; Stuart FP
    Transplantation; 1973 Nov; 16(5):432-40. PubMed ID: 4584953
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxic and enhancing properties of early gammaM alloantibodies elicited by first set renal allografts. In vitro and in vivo studies with rat and guinea pig complement on somatic target cells with varying antigen density.
    van Breda Vriesman PJ; Swanen-Sierag L; Vlek LF
    Transplantation; 1975 Nov; 20(5):385-92. PubMed ID: 1108313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts.
    Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA
    Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive enhancement of homozygous renal allografts in the rat.
    Fabre JW; Morris PJ
    Transplantation; 1974 Nov; 18(5):429-35. PubMed ID: 4610921
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement.
    Soulillou JP; Carpenter CB; d'Apice AJ; Strom TB
    J Exp Med; 1976 Feb; 143(2):405-21. PubMed ID: 129499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.